Total tumor volume predicts overall survival and response to induction chemotherapy in patients with colorectal cancer liver metastases: An ancillary study of the phase 3 CAIRO5 trial.
Michiel Zeeuw J, Kemna R, Ali M, van Eck S, Wesdorp NJ, Roor J, van Waesberghe JHTM, van den Bergh JE, Nota IMGC, Moos SI, van Dieren S, van Amerongen MJ, Bond MJG, Chapelle T, van Dam RM, Engelbrecht MRW, Gerhards MF, Grunhagen DJ, van Gulik TM, Hermans JJ, de Jong KP, Klaase JM, Kok NFM, Leclercq WKG, Liem MSL, van Lienden KP, Quintus Molenaar I, Patijn GA, Rijken AM, Ruers TM, Verhoef C, de Wilt JHW, Buffart TE, Swijnenburg RJ, Punt CJA, Verpalen IM, Stoker J, Huiskens J, Kazemier G; CAIRO5 research group.
Michiel Zeeuw J, et al. Among authors: kok nfm.
Eur J Cancer. 2025 Oct 1;228:115738. doi: 10.1016/j.ejca.2025.115738. Epub 2025 Aug 21.
Eur J Cancer. 2025.
PMID: 40912057
Free article.
Clinical Trial.